The FDA has granted fast-track designation to nipocalimab for the treatment of Sjögren’s disease, according to a press ...
Otsuka’s Taiho Pharmaceutical is paying $400 million upfront to acquire Switzerland’s Araris Biotech and its antibody-drug ...
Proteintech has designed recombinant antibodies featuring the company's FcZero backbone, engineered to silence the Fc domain ...
Complementing its antibody offerings, BosterBio provides a range of ELISA kits designed for quantitative detection of ...
Data highlights potential of CD388 as a potent, universal antiviral for influenza prevention regardless of immune statusSAN DIEGO, March 17, ...
Company expects to have sufficient cash to fund planned operations beyond the FDA PDUFA goal date and anticipated fourth ...
The Federal Circuit says that you must disclose and describe the prior art, or your Jepson claim is invalid. Obviously, this ...
7 天
Pharmaceutical Technology on MSNLundbeck’s amlenetug gains orphan drug status in Japan for MSALundbeck has gained orphan drug designation (ODD) from Japan’s Ministry of Health, Labor and Welfare (MHLW) for amlenetug to ...
After hours: March 17 at 4:05:11 PM EDT Loading Chart for FC ...
Taiho Pharmaceutical Co., Ltd.Araris Biotech AGTaiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris ...
It performs an enzymatic modification method of IgG Fc glycans to perform conjugation. AGLink requires no prior engineering of the amino acid sequence, resulting in stable antibody conjugates ...
We expect these to return in EA FC 25 once again. The devs also like to throw new special card campaigns into the mix as well, but these won’t be announced until a day or two before they are due ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果